Gall Matthew

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Gall Matthew's trades of Iteos Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-19 2024-11-19 B Purchase
78,785 -16.0%
240.29
US$4,916,331
78,785 -16.0% 240.29 US$4,916,331
2023-10-12 2023-10-12 B Purchase
33,269 +7.9%
280.10
US$377,358
33,269 +7.9% 280.10 US$377,358
2021-06-16 2021-06-16 B Purchase
33,457 +46.3%
265.46
US$2,182,038
33,457 +46.3% 265.46 US$2,182,038